United Capital Financial Advisers, LLC Enochian Biosciences Inc Transaction History

United Capital Financial Advisers, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.93 - $8.73 $137,591 - $622,370	-71,291 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.56 - $7.88 $107,615 - $185,968	23,600 Added 49.49%	71,291 $480,000
Q2 2021 Aug 13, 2021	SELL	$2.94 - $6.79 $69,384 - $160,244	-23,600 Reduced 33.1%	47,691 $237,000
Q1 2021 May 14, 2021	BUY	$3.02 - $4.51 $52,517 - $78,428	17,390 Added 32.26%	71,291 $252,000
Q4 2020 Feb 17, 2021	SELL	$2.82 - $3.55 $56,143 - $70,676	-19,909 Reduced 26.97%	53,901 $159,000
Q3 2019 Nov 14, 2019	BUY	$3.95 - $5.72 $199,119 - $288,345	50,410 Added 215.43%	73,810 $406,000
Q2 2019 Aug 13, 2019	BUY	$4.5 - $6.99 $105,300 - $163,566	23,400 New	23,400 $105,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.